- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02999971
Effects of an Aquatic Therapy Program Versus a Land Program in Patients Who Suffered a Stroke
March 30, 2020 updated by: IRENE PEGITO PEREZ, Universidade da Coruña
Effects of an Aquatic Circuit Class Therapy Program Versus a Land Circuit Class Therapy Program in Patients Who Suffered a Stroke
The objective of this study is to investigate the relative effectiveness of CCT on water versus on land in stroke patients.
Additionally, the study will to determine if there are differences in the results obtained, between two CCT programs in the following parameters: gait, balance and dexterity
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is a randomized controlled trial of the effectiveness of a structured CCT program in water versus a structured CCT program on land in the rehabilitation of stroke survivors.
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with diagnosis of stroke (ischemic or hemorrhagic) onset ≤ 3 years; with hemiparesis secondary;
- age ≥18 to ≤ 90;
- provide a written informed consent;
- able to walk for at least 10 m without assistance
Exclusion Criteria:
- patients with uncontrolled or risky conditions (acute myocardial infarction, arrhythmia, heart failure, uncontrolled hypertension or unstable cardiovascular state);
- with infectious diseases, ulcers or urinary and / or faecal incontinence;
- additional neurological and / or orthopedic deficits that alter ambulation;
- unable to follow treatment (cognitive, visual ...).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: circuit class therapy in water
CCT on water.
The intervention developed in this study will be through the realization of an exercise program in circuit (CCT).
One of the groups will receive treatment in the water (intervention group), and the other on land (control group).
In both groups, the intervention will be a 7-week class therapy, 3-times weekly, giving a total of 20 sessions.
|
The circuit, the main part of the session, include a series of 10 different workstations, arranged to progress in complexity, in order to work several segments of the body, oriented towards a functional recovery objective.
These stations will be made up of task-specific activities for gait, balance and dexterity.
Time in each workstation will be 5 minutes divided as follows: 4 minutes work period and 1 minute rest period, of these, last 30 seconds will be change period for crossing from one workstation to the next.
After 50 minutes, each patient will have covered the 10 workstations, thus working in all of the objectives pursued in the realization on this CCT: gait, balance and dexterity.
|
|
Experimental: circuit class therapy on land
CCT on land.
The intervention developed in this study will be through the realization of an exercise program in circuit (CCT).
One of the groups will receive treatment in the water (intervention group), and the other on land (control group).
In both groups, the intervention will be a 7-week class therapy, 3-times weekly, giving a total of 20 sessions.
|
The circuit, the main part of the session, include a series of 10 different workstations, arranged to progress in complexity, in order to work several segments of the body, oriented towards a functional recovery objective.
These stations will be made up of task-specific activities for gait, balance and dexterity.
Time in each workstation will be 5 minutes divided as follows: 4 minutes work period and 1 minute rest period, of these, last 30 seconds will be change period for crossing from one workstation to the next.
After 50 minutes, each patient will have covered the 10 workstations, thus working in all of the objectives pursued in the realization on this CCT: gait, balance and dexterity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
10 meters walk test
Time Frame: 60 seconds
|
60 seconds
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Test Up & Go
Time Frame: 5 minutes
|
5 minutes
|
|
Berg Balance Scale (BBS)
Time Frame: 20 minutes
|
20 minutes
|
|
Romberg Test
Time Frame: 1 minute
|
1 minute
|
|
Fugl-Meyer Assessment
Time Frame: 15 minutes
|
15 minutes
|
|
Functional Reach Test (FRT)
Time Frame: 10 minutes
|
10 minutes
|
|
Box and block test
Time Frame: 5 minutes
|
5 minutes
|
|
Self-efficacy Scale
Time Frame: 5 minutes
|
5 minutes
|
|
Activities-Specific Balance Confidence Scale (ABC)
Time Frame: 10 minutes
|
10 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
June 1, 2019
Study Registration Dates
First Submitted
December 18, 2016
First Submitted That Met QC Criteria
December 20, 2016
First Posted (Estimate)
December 21, 2016
Study Record Updates
Last Update Posted (Actual)
March 31, 2020
Last Update Submitted That Met QC Criteria
March 30, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UCoruna
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.